Evidence map›Paper›PMID 31720205›Full record

ArticleRespiratory medicine case reports2019

A case of pulmonary tumor thrombotic microangiopathy associated with lung cancer diagnosed by cell-block immunohistochemistry of pulmonary microvascular cytology.

Hideaki Yamakawa, Tomohiro Oba, Hiroki Ohta, Yuta Tsukahara, Gen Kida, Emiri Tsumiyama, Tomotaka Nishizawa, Rie Kawabe, Shintaro Sato, Keiichi Akasaka and 3 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory medicine case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Hideaki YamakawaDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
Tomohiro ObaDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
Hiroki OhtaDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
Yuta TsukaharaDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
Gen KidaDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
Emiri TsumiyamaDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
Tomotaka NishizawaDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
Rie KawabeDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
Shintaro SatoDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
Keiichi AkasakaDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
Masako AmanoDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
Kazuyoshi KuwanoDepartment of Respiratory Medicine, Tokyo Jikei University Hospital, Tokyo, Japan.
Hidekazu MatsushimaDepartment of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
Saitama Red Cross Hospital · JPThe Jikei University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary tumor thrombotic microangiopathy (PTTM) is rare but should be considered as a possible diagnosis in patients with cancer. In this case, PTTM induced by lung cancer was more accurately diagnosed using cell block immunohistochemistry of pulmonary microvascular cytology (PMC) because we could confirm that lung adenocarcinoma was the origin of PTTM by the positive result of TTF-1 for atypical cells in PMC. The PMC procedure was minimally invasive and safer than lung biopsy. We believe that the cell block technique of PMC should be considered as one diagnostic option in PTTM.

Indexed as

Cell block techniquePulmonary microvascular cytologyPulmonary tumor thrombotic microangiopathy

Identifiers

PMID31720205
PMCPMC6838463
OpenAlexW2981351248

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.